Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
STOK
#2008
Stoke Therapeutics, Inc. - Common Stock
30.7
9
USD
-2.53%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-2.53%
Monthly Change
-6.19%
6 month change
+0.20%
Year Change
+220.06%
Previous Close
31.5
9
Open
30.9
7
Low
30.6
8
High
31.0
2
Volume
65
Markets
US Stock Market
Healthcare
STOK
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Current
Key stats
Total common shares outstanding
54.08 M
54.6 M
54.8 M
57.12 M
59.15 M
62.28 M
62.28 M
Valuation ratios
Enterprise value
468.49 M
88.25 M
520.48 M
1.26 B
1.79 B
1.87 B
1.69 B
Price to earnings ratio
-6.68
8.11
12.9
33.57
-264.5
-11.59
-10.56
Price to sales ratio
16.3
2.03
3.33
6.72
10.19
60.23
54.88
Price to cash flow ratio
6.86
1.96
4.31
13.66
41.23
-13.41
-12.22
Price to book ratio
2.6
0.35
0.56
1.13
5.33
1.4
1.28
Enterprise value to EBITDA ratio
-4.72
2.19
12.31
43.28
-95.28
-10.2
-9.22
Profitability ratios
Return on assets %
-0.04
0.28
-0.06
-0.11
-0.14
-0.11
-0.11
Return on equity %
-0.05
0.32
-0.07
-0.12
-0.16
-0.13
-0.13
Return on invested capital %
—
643
-76.5
-129.54
-185.11
-167.59
-167.59
Gross margin %
100
100
100
100
100
100
100
Operating margin %
-60.38
70.15
-197.58
-405.3
-4 382.24
-857.57
-857.57
EBITDA margin %
-58.06
70.45
-194.35
-401.14
-4 353.35
-850.52
-850.52
Net margin %
-46.35
71.19
-169.96
-360.68
-4 132.24
-802.75
-802.75
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
5.81
8.41
6.98
6.53
5.28
8.99
8.99
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.08
0.47
0.04
0.03
0
0.01
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.43
2.22
-0.44
-0.52
-0.51
-0.96
-2.43
EBIT per share
-0.25
1.87
-0.47
-0.74
-1.04
-0.85
-3.09
EBITDA per share
-0.24
1.88
-0.46
-0.73
-1.03
-0.84
-3.06
Total debt per share
—
—
—
—
—
—
—
Cash per share
4.02
6.02
4.24
4.24
4.81
5.45
5.45
Net current asset value per share
4.31
6.33
4.63
4.65
5.16
5.81
5.81
Tangible book value per share
4.24
5.89
5.74
5.26
5.95
6.26
6.26
Working capital per share
3.57
5.57
3.96
3.94
4.18
5.17
5.17
Book value per share
4.24
5.89
5.74
5.26
5.95
6.26
6.26
News
Is it a Good Idea to Invest in Stoke Therapeutics Stock Now?
Stoke Therapeutics, Inc. (STOK) Q1 2026 Earnings Call Transcript
Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates
Recursion Pharmaceuticals (RXRX) Reports Q1 Loss, Lags Revenue Estimates
Rocket Lab Soars, Leads 14 Onto Today's Premium Stock Screens
Orchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates
Vertex (VRTX) Moves 8.3% Higher: Will This Strength Last?
Stoke Therapeutics stock hits 52-week high at 39.88 USD
Stoke Therapeutics earnings in focus amid Dravet trial progress
Dianthus Therapeutics, Inc. (DNTH) Stock Jumps 12.0%: Will It Continue to Soar?
We Told You So — These IBD 50 Stocks Dominate This Year
Natural Gas Giant Williams Leads 19 Stocks New To IBD Best Stock Lists